Beam Therapeutics Inc. (BEAM) vs Neogen Corporation (NEOG)
A side-by-side comparison of Beam Therapeutics Inc. and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BEAM
Beam Therapeutics Inc.
$25.18HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
NEOG
Neogen Corporation
$12.15HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — BEAM vs NEOG
growth of $100 · dividends reinvested · last 7yBEAM +36.9% (+4.6%/yr)NEOG -62.7% (-13.1%/yr)BEAM compounded faster over this window
BEAM NEOG
BEAM vs NEOG: by the numbers
- •NEOG is the larger company ($2.65B vs $2.59B market cap).
- •Both run net losses; NEOG's is the smaller (-0.91% vs -54.75% net margin).
- •BEAM grew revenue faster over the past five years (479.04% vs 13.19% CAGR).
Metrics side by side
Valuation
| Metric | BEAM | NEOG |
|---|---|---|
| Forward P/E | N/A | 39.19 |
| P/S ratio | 16.60 | 3.04 |
| P/B ratio | 2.43 | 1.27 |
| EV / EBITDA | N/A | 32.49 |
Profitability
| Metric | BEAM | NEOG |
|---|---|---|
| Gross margin | 84.05% | 46.93% |
| Operating margin | -274.57% | -2.49% |
| Net margin | -54.75% | -0.91% |
| ROE | -8.00% | -0.38% |
| ROIC | -28.96% | -0.68% |
Growth (annualized)
| Metric | BEAM | NEOG |
|---|---|---|
| Revenue CAGR (5Y) | 479.04% | 13.19% |
| Total return CAGR (5Y) | -21.41% | -21.13% |
Frequently asked
- Which has grown faster, BEAM or NEOG?
- Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus NEOG at 13.19%.
- How have BEAM and NEOG total returns compared?
- Over the past 5 years, BEAM delivered -21.41% and NEOG delivered -21.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Beam Therapeutics ROENeogen ROEBeam Therapeutics operating marginNeogen operating marginBeam Therapeutics revenue growthNeogen revenue growthBeam Therapeutics free cash flowNeogen free cash flow
Beam Therapeutics & Neogen appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.